Altered angiogenic balance in keloids: A key to therapeutic intervention

Translational Research

Volumn 159, Issue 3, 2012, Pages 182-189

  Mogili, Nirupa Shyam ^a,b,c,d   Krishnaswamy, Venkat Raghavan ^a,b,c,d   Jayaraman, Meenakshi ^a,b,c,d   Rajaram, Rama ^a,b,c,d   Venkatraman, Alamelu ^a,b,c,d   Korrapati, Purna Sai ^a,b,c,d  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b MADRAS MEDICAL COLLEGE   (India)

^c Sri Jayam Hospital   (India)

^d KJ Hospital and Research Foundation   (India)

Author keywords

cDNA; complementary DNA; ECM; ELISA; enzyme linked immunosorbent assay; extracellular matrix; IgG; immunoglobulin G; matrix metalloprotease; MMP; PCR; polymerase chain reaction; SD; SDS; SDS PAGE; serum vascular endothelial growth factor; sodium dodecyl sulfate; sodium dodecyl sulfate polyacrylamide gel electrophoresis; standard deviation; sVEGF; TIMP; tissue inhibitor of matrix metalloprotease; vascular endothelial growth factor; VEGF

Indexed keywords

BETA ACTIN; ENDOSTATIN; VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; KELOID; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE LEVEL; UPREGULATION;

EID: 84857264194     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.10.002     Document Type: Article

References (32)

1. M.S. O'Reilly, T. Boehm, and Y. Shing Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285 (Pubitemid 28015876)
2. A. Abdollahi, L. Hlatky, and P.E. Huber Endostatin: the logic of antiangiogenic therapy Drug Resist Updat 8 2005 59 74 (Pubitemid 40797957)
3. W. Bloch, K. Huggel, and T. Sasaki The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing FASEB J 14 2000 2373 2376
4. L. Seppinen, R. Sormunen, and Y. Soini Lack of collagen XVIII accelerates cutaneous wound healing, while overexpression of its endostatin domain leads to delayed healing Matrix Biol 27 2008 535 546
5. L. Louw The keloid phenomenon: progress toward a solution Clin Anat 20 2007 3 14 (Pubitemid 44893986)
6. C.W. Kischer The microvessels in hypertrophic scars, keloids and related lesions: a review J Submicrosc Cytol Pathol 24 1992 281 296
7. Q. Zhang, C.K. Oh, and D.V. Messadi Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt Exp Cell Res 312 2006 145 155 (Pubitemid 41721177)
8. A.S. Vincent, T.T. Phan, A. Mukhopadhyay, H.Y. Lim, B. Halliwell, and K.P. Wong Human skin keloid fibroblasts display bioenergetics of cancer cells J Invest Dermatol 128 2008 702 709 (Pubitemid 351252674)
9. B. Shih, E. Garside, D.A. McGrouther, and A. Bayat Molecular dissection of abnormal wound healing processes resulting in keloid disease Wound Repair Regen 18 2010 139 153
10. A. Al-Attar, S. Mess, J.M. Thomassen, C.L. Kauffman, and S.P. Davison Keloid pathogenesis and treatment Plast Reconstr Surg 117 2006 286 300 (Pubitemid 44391579)
11. I. Appleton, N.J. Brown, and D.A. Willoughby Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids Am J Pathol 149 1996 1441 1447 (Pubitemid 26363950)
12. D.S. Steinbrech, B.J. Mehrara, and D. Chau Hypoxia upregulates VEGF production in keloid fibroblasts Ann Plast Surg 42 1999 514 519
13. A.K. Gira, L.F. Brown, C.V. Washington, C. Cohen, and J.L. Arbiser Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor J Am Acad Dermatol 50 2004 850 853 (Pubitemid 38685763)
14. C.T. Ong, Y.T. Khoo, and E.K. Tan Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion J Pathol 211 2007 95 108 (Pubitemid 46092034)
15. A.L. Feldman, H. Pak, J.C. Yang, H.R. Alexander Jr., and S.K. Libutti Serum endostatin levels are elevated in patients with soft tissue sarcoma Cancer 91 2001 1525 1529 (Pubitemid 32319264)
16. B. Dziankowska-Bartkowiak, E. Waszczykowska, A. Zalewska, and A. Sysa-Jedrzejowska Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients Mediators Inflamm 2005 2005 144 149 (Pubitemid 41381522)
17. S. Takeshita, Y. Kawamura, H. Takabayashi, N. Yoshida, and S. Nonoyama Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease Clin Exp Immunol 139 2005 575 579 (Pubitemid 40333270)
18. F.V. Okur, C. Karadeniz, and M. Buyukpamukcu Clinical significance of serum vascular endothelial growth factor, endostatin and leptin levels in children with lymphoma Pediatr Blood Cancer 55 2010 1272 1277
19. L. Seppinen, and T. Pihlajaniemi The multiple functions of collagen XVIII in development and disease Matrix Biol 30 2011 83 92
20. A.N. Neely, C.E. Clendening, J. Gardner, D.G. Greenhalgh, and G.D. Warden Gelatinase activity in keloids and hypertrophic scars Wound Repair Regen 7 1999 166 171 (Pubitemid 29331920)
21. O. Seifert, A. Bayat, and R. Geffers Identification of unique gene expression patterns within different lesional sites of keloids Wound Repair Regen 16 2008 254 265 (Pubitemid 351342120)
22. S. Tanriverdi-Akhisaroglu, A. Menderes, and G. Oktay Matrix metalloproteinase - 2 and - 9 activities in human keloids, hypertrophic and atrophic scars: a pilot study Cell Biochem Funct 27 2009 81 87
23. R. Heljasvaara, P. Nyberg, and J. Luostarinen Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases Exp Cell Res 307 2005 292 304 (Pubitemid 40799357)
24. S.J. Lee, J.W. Jang, and Y.M. Kim Endostatin binds to the catalytic domain of matrix metalloproteinase-2 FEBS Lett 519 2002 147 152
25. A. Abdollahi, P. Hahnfeldt, and C. Maercker Endostatin's antiangiogenic signaling network Mol Cell 13 2004 649 663 (Pubitemid 38368123)
26. J. Hanai, J. Gloy, and S.A. Karumanchi Endostatin is a potential inhibitor of Wnt signaling J Cell Biol 158 2002 529 539 (Pubitemid 34851711)
27. M. Sato Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids Acta Derm Venereol 86 2006 300 307 (Pubitemid 44133374)
28. Y. Wu, Q. Zhang, and D.K. Ann Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts Am J Physiol Cell Physiol 286 2004 C905 C912
29. M. Babu, R. Diegelmann, and N. Oliver Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing Mol Cell Biol 9 1989 1642 1650 (Pubitemid 19095205)
30. Y.C. Hsu, M. Hsiao, L.F. Wang, Y.W. Chien, and W.R. Lee Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation Nitric Oxide 14 2006 327 334 (Pubitemid 43816315)
31. J.C. Smith, B.E. Boone, S.R. Opalenik, S.M. Williams, and S.B. Russell Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways J Invest Dermatol 128 2008 1298 1310 (Pubitemid 351543197)
32. V. Prathiba, R. Kumaresan, M. Babu, and P.D. Gupta Ultrastructural studies of keloids Biomed Lett 58 1998 41 50